IQV Iqvia Holdings Inc
- Stocks
- Healthcare
- NYSE: IQV
Price (delayed)
$199.17
Market cap
$33.86B
P/E Ratio
28.58
Dividend/share
N/A
EPS
$6.97
Enterprise value
$47.52B
IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development
Highlights
IQV's revenue is up by 3.6% YoY
The price to earnings (P/E) is 44% lower than the 5-year quarterly average of 50.8 but 11% higher than the last 4 quarters average of 25.8
Iqvia Holdings's debt has increased by 17% YoY and by 8% from the previous quarter
The equity has contracted by 14% YoY and by 3.3% from the previous quarter
Key stats
What are the main financial stats of IQV
Market
Valuations
Earnings
Shares outstanding
170M
Market cap
$33.86B
Enterprise value
$47.52B
Price to earnings (P/E)
28.58
Price to book (P/B)
5.96
Price to sales (P/S)
2.18
EV/EBIT
21.42
EV/EBITDA
14.22
EV/Sales
3.03
Revenue
$15.7B
Gross profit
$5.38B
Operating income
$2.18B
Net income
$1.24B
EBIT
$2.22B
EBITDA
$3.34B
Free cash flow
$2.01B
Per share
Balance sheet
Liquidity
EPS
$6.97
EPS diluted
$6.9
Free cash flow per share
$11.7
Book value per share
$33.4
Revenue per share
$91.39
TBVPS
$49.04
Total assets
$28.63B
Total liabilities
$22.85B
Debt
$15.7B
Equity
$5.78B
Working capital
-$1.23B
Debt to equity
2.72
Current ratio
0.84
Quick ratio
0.73
Net debt/EBITDA
4.09
Margins
Efficiency
Dividend
EBITDA margin
21.3%
Gross margin
34.2%
Net margin
7.9%
Operating margin
13.9%
Return on assets
4.5%
Return on equity
20%
Return on invested capital
16.6%
Return on capital employed
10.5%
Return on sales
14.1%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
IQV stock price
How has the Iqvia Holdings stock price performed over time
Intraday
-0.82%
1 week
23.99%
1 month
25.49%
1 year
-14.26%
YTD
1.35%
QTD
26.38%
Financial performance
How have Iqvia Holdings's revenue and profit performed over time
Revenue
$15.7B
Gross profit
$5.38B
Operating income
$2.18B
Net income
$1.24B
Gross margin
34.2%
Net margin
7.9%
Iqvia Holdings's net margin has decreased by 16% YoY and by 8% from the previous quarter
Iqvia Holdings's net income has decreased by 13% YoY and by 7% QoQ
IQV's operating income is up by 8% year-on-year
Iqvia Holdings's operating margin has increased by 5% YoY
Price vs fundamentals
How does IQV's price correlate with its fundamentals
Growth
What is Iqvia Holdings's growth rate over time
Valuation
What is Iqvia Holdings stock price valuation
P/E
28.58
P/B
5.96
P/S
2.18
EV/EBIT
21.42
EV/EBITDA
14.22
EV/Sales
3.03
The price to earnings (P/E) is 44% lower than the 5-year quarterly average of 50.8 but 11% higher than the last 4 quarters average of 25.8
IQV's EPS is down by 11% year-on-year and by 6% since the previous quarter
The equity has contracted by 14% YoY and by 3.3% from the previous quarter
The stock's price to book (P/B) is 10% less than its 5-year quarterly average of 6.6 but 8% more than its last 4 quarters average of 5.5
The stock's price to sales (P/S) is 22% less than its 5-year quarterly average of 2.8
IQV's revenue is up by 3.6% YoY
Efficiency
How efficient is Iqvia Holdings business performance
IQV's return on assets is down by 17% year-on-year and by 8% since the previous quarter
The ROE has decreased by 12% YoY and by 3.4% QoQ
The company's return on invested capital fell by 7% QoQ
IQV's return on sales is down by 5% since the previous quarter and by 2.1% year-on-year
Dividends
What is IQV's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for IQV.
Financial health
How did Iqvia Holdings financials performed over time
The total assets is 25% greater than the total liabilities
Iqvia Holdings's total liabilities has increased by 16% YoY and by 7% QoQ
The total assets is up by 8% year-on-year and by 4.8% since the previous quarter
Iqvia Holdings's debt is 172% more than its equity
The debt to equity has increased by 36% YoY and by 12% from the previous quarter
Iqvia Holdings's debt has increased by 17% YoY and by 8% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.